Andrew Clark

Axol Bioscience Ltd. is a biotech company that develops and produces induced pluripotent stem cell-derived clinically relevant cells for use in biomedical research and discovery. Its products include human neural progenitor cells, young frozen human cerebral cortical neurons, plated human cerebral cortical neurons, Alzheimer's disease human neural progenitor cells, reagents, and lipid-based transfection reagents. The firm's products are used in the testing of new drug compounds, as well as in the development of therapies for various diseases, such as Alzheimer’s. The company was founded by Yichen Shi and Jonathan Simon Milne and is headquartered in Cambridge, the United Kingdom.

DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom.

GeoSpock Ltd. provides data software products. It offers illumin, extrapol and cogn8 products. The company was founded by Steven Marsh and Darrin Mathew Disley in 2013 and is headquartered in Cambridge, the United Kingdom.

Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.

PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom.

Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom.

Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA.

Avocet 66 Ltd. is a British financial intermediary company founded in 2017.

Peregrine 66 Ltd. is a British investment services company founded in 2017. The private company is based in London, UK. The company provides investment services.

Suntail 66 Ltd. provides financial intermediary services. The private company is based in London, UK.

Start Codon Ltd (Start Codon) is a venture capital firm founded in 2018 by Jason Mellad and Marek Tyl. The firm is headquartered in London, United Kingdom.

Part of Clearway Global LLC, Altemia & Co. LLC is a medical food company. The company is based in Stuart, FL. Altemia & Co. was acquired by Lobe Sciences Ltd. on April 29, 2024 for $1.01 million.

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.